Company / Free Cash Flow per Share
Immunome Inc. Free Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$3.11
FY2025
5-year range
-$3.11 / -$0.19
FY2021-FY2025
Trend
-1502.6%
vs FY2024
Sector context
#151 of 192
Health Care
What the data says
Free Cash Flow per Share changed -1503% YoY in FY2025, a notable deviation from the 6-year average annual change of -224%.
Based on SEC 10-K filings.
-3.11 in FY2025.
Declined from $-2.39 to $-3.11 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 192This company -$3.11 Sector average $3.32
▼
-193.8% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 1502.6% year-over-year.
- Ranks #151 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2024.
- Lowest free cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 4.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.11 | -1502.6% |
| FY2024 | -$0.19 | +91.9% |
| FY2023 | -$2.39 | +0.0% |
| FY2022 | -$2.39 | -50.4% |
| FY2021 | -$1.59 | +57.7% |
| FY2020 | -$3.75 | +58.3% |
| FY2019 | -$8.99 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026